Analysis of the colorectal tumor microenvironment using integrative bioinformatic tools

Size: px
Start display at page:

Download "Analysis of the colorectal tumor microenvironment using integrative bioinformatic tools"

Transcription

1 MLECNIK Bernhard & BINDEA Gabriela Analysis of the colorectal tumor microenvironment using integrative bioinformatic tools INSERM U872, Jérôme Galon Team15: Integrative Cancer Immunology Cordeliers Research Center, Paris, France

2 Introduction Colorectal cancer, TNM staging I / II No - therapy Tumor(T) Lymph node(n) Metastasis(M) Surgery Patient Classification Stage III / IV 0% Relapse 100% Relapse Kaplan Mayer Survival Curves for the postoperative follow up of ~400 Patients Chemo - therapy

3 Immune infiltration predicts patient outcome in colorectal cancer Mechanisms? Galon et al. Science 2006

4 Immune infiltration predicts patient outcome in colorectal cancer High immune infiltration CD3 Tumor Low immune infiltration Galon et al. Science 2006 Mlecnik et al. JCO 2011

5 Objective - What are the molecular mechanisms leading to high intra-tumoral memory T cell densities and good prognosis -> Applying biomolecular network enrichment using in silico prediction and bioinformatic tools to generate hypotheses

6 Overview 1. Integrative analysis of the colorectal tumor microenvironment 2. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks

7 Large amount of data Affymetrix LDA 105 pts 125 pts TCR Repertoire FACS 20 pts 30 pts TMA acgh MSI 216 pts 280 pts SNP Integrative analysis at gene & protein level 648 pts 50 pts Mlecnik et al. BMC Genomics. 2010

8 TME analysis modules, R based - KM curves - ROC curves - Parametric, Non-parametric tests - correlation Analysis of pathways: PathwayExplorer From genes to networks of functions: ClueGO Mlecnik et al. Nucleic Acids Res 2005 Bindea, Mlecnik et al. Bioinformatics 2009 Mlecnik et al. BMC Genomics. 2010

9 Search tool for predicting functional interactions (STRING) Conserved Genomic Neighborhood (630 fully sequenced organisms) Gene Fusion Co-occurrence Co-expression Analysis Experiments Functional Genomic Databases predicted genes Textmining (16 million PubMed references) -> Weighted Score for links between known and predicted genes -> in silico prediction of functional interactions between genes Jensen et al. Nucleic Acids Res. 2009

10 Biomolecular Network Enrichment qpcr for 48 selected immune and tumor genes analysed in 104 colorectal cancer (CRC) patients 12 log-rank significant genes for disease free survival (DFS) at median cut-off for high vs. low gene expression, p<0.05 In silico enrichment using the 12 significant genes (STRING) Top predicted genes Network of experimental + enriched genes (Cytoscape, GOlorize)

11 In silico network In silico network, 48 initial genes, shown with top enriched genes Edge thickness: r < r < 0.8 r 0.8 Innate and adaptive immune genes Edge Colors: Pro-inflamatory Pearson correlation Combined correlation STRING and Pearson Cytotoxic immune response Th1 T cell activation Negative reg of immune response Angiogensis Immuno suppressive Th2 Metastasis spreading Nodes colored by GO categories STRING combined score Node size: log-rank P-values Tumor invasion P-value < P-value 0.05 P-value 0.01 STRING predicted top 40 Mlecnik et al. Gastroenterology. 2010

12 Hypothesis generation based on ClueGO analysis List1 List2 48 genes qpcr 65 in silico predicted genes 14 functional annotations specific for List2 GO 991 Terms 1110 Terms Chemotaxis ClueGO 9 14 Cell adhesion ClueGO: Bindea, Mlecnik et al. Bioinformatics 2009

13 Analysis of immune cell densities within the tumor CK8 (blue) / CD8 (brown) CX3CL1 Cells/mm2 CX3CL1 - Lo CXCL9 - Lo CXCL10 - Lo CD8-CT Cells/mm2 Tissue Microarrays Cells/mm2 Hi Lo P< CXCL9 CX3CL1 - Hi CXCL9 - Hi CXCL10 - Hi 0 P=0.05 Hi Lo CXCL10 0 P<0.05 Hi Lo

14 Analysis of immune cell densities within the tumor Flow cytometry CD3+CD8+ % total cells P=0.07 Hi P<0.05 Hi Lo Hi Lo P<0.05 Hi Lo CXCL10 0 P= % total cells CXCL9 4 0 Lo % total cells CX3CL1 CD3+TCRαβ+ 0 P<0.05 Hi Lo 4 0 P<0.05 Hi Lo

15 Tissue micro array (TMA) analysis in the center (CT) and in the invasive margin (IM) of the tumor P values Th1, Activated T Cytotoxic T cells, NK cells Memory T cells Macrophages Mlecnik et al. Gastroenterology Bindea, Mlecnik et al. Curr Opin Immunol. 2010

16 Analysis of immune cell densities within the tumor Highly polyclonal repertoire (V-D-J) All Vβ are present Vβ CDR3 length Overall Survival (%) Most CDR3 lengths are represented TCR Vβ2L Hi Lo Specific T cells are associated with High/Low expression of CX3CL1 and with the overall Months survival of the patients Mlecnik et al. Gastroenterology Bindea, Mlecnik et al. Curr Opin Immunol. 2010

17 T cell receptor β gene (TCRB) rearrangement. Hodges E et al. J Clin Pathol 2003;56: by BMJ Publishing Group Ltd and Association of Clinical Pathologists

18 Conclusions - Biomolecular network creation using in silico prediction reveals potential genes associated to colorectal cancer outcome - The predicted chemokines and adhesion molecules are correlated with the in situ immune cell density - Specific chemokines may attract distinct populations of immune cells, including subpopulations of T cells with a particular repertoire (TCR receptors) - These specific T cells are associated with patient survival

19 ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks

20 The challenge: biological interpretation of large gene lists Biological role Gene Ontology (GO) KEGG BioCarta PathwayExplorer Cytoscape GO: controlled vocabulary (terms) that can be used to describe any organism. It has hierarchical structure (parentchild relations between the terms) KEGG, BioCarta, PathwayExplorer: pathway analysis Cytoscape: visualization of biological networks

21 The challenge: biological interpretation of large gene lists Gene Ontology: T cell receptor related terms (#22) GOID GOTerm # of Associated Genes Type of Ontology

22 The challenge: biological interpretation of large gene lists BioCarta: T cell receptor signaling pathway

23 The challenge: biological interpretation of large gene lists KEGG: T cell receptor signaling pathway

24 The challenge: biological interpretation of large gene lists PathwayExplorer: gene expression mapped to pathways Mlecnik et al. Nucleic Acids Res 2005

25 Different data sources and tools for biological interpretation of large lists of genes List of genes Experiment KEGG BIOCARTA PathwayExplorer Pathways Cytoscape Gene network GO database Terms Difficulties - Different annotation sources - Redundant information - Many functional annotations for each gene - Identification of related genes

26 Example 238 genes mapped in GO => 1504 terms expansion of knowledge... instead of going to the essence

27 Objectives To develop ClueGO, a tool for extracting the global, non-redundant functional information for lists of genes To provide intuitive, comprehensive representation of the results To integrate ClueGO with existing tools for analysis of high-throughput experiments

28 Integration of different data sources and tools for biological interpretation of large lists of genes with ClueGO List of genes Experiment KEGG BIOCARTA Pathways Cytoscape Gene network ClueGO Term network Charts Statistics GO database Terms

29 ClueGO Java programming language System requirements Windows, Linux, Unix or MacOS 1024MB RAM + Java 1.5+ Cytoscape Up to date 14 organisms available

30 ClueGO, a Cytoscape plugin ClueGO Network ClueGO Results ClueGO ControlPanel

31 ClueGO, a Cytoscape plugin Chart (Terms)

32 ClueGO, a Cytoscape plugin OverviewChart (Groups)

33 ClueGO, a Cytoscape plugin ClueGO settings summary Advanced settings

34 Redundancy reduction 142 significantly differentially expressed (CRC/CN, wilcoxon, p<0.05) LDA3 genes 238 nonsignif LDA3 genes GO mapping ClueGO LDA3 significant genes LDA3 nonsignificant genes 1504 GO Terms 1074 GO Terms

35 Next challenge: comparison of patterns based on functional analysis List A List B Common GO terms GO terms specific List A GO terms specific List B creation of functional networks

36 Functional analysis for two lists of genes Groups network

37 Functional analysis for two lists of genes Genes distribution network %GenesList A 1:1 GenesListA-B %GenesListB

38 ClueGO fast extraction of biological information from a large data volume 1. Reduces the redundancy (fusion of similar terms) 2. Visualize the terms in a functionally grouped network 3. Compare the ontology of two lists of genes 4. Automatically calculates statistics (FisherExactTest) 5. Result Folder (network, charts,.cys file, matrix) 6. Provides predefined settings 7. User friendly update and organism extension

39 Open access: Bindea, Mlecnik et al. Bioinformatics 2009

40 Summary - ClueGO strongly improves biological interpretation of large lists of genes by analyzing interrelations of corresponding GO/pathway terms and functional groups in biological networks - It can be integrated with existing tools used for the analysis of high-throughput data

41 Acknowledgments INSERM U872, Integrative Cancer Immunology Team Jérôme Galon Marie Tosolini Amos Kirilovsky Franck Pagès Melanie Gillard Tessa Fredriksen Stephanie Mauger Cordeliers Research Center Wolf-Herman Fridman

42 MLECNIK Bernhard & BINDEA Gabriela Analysis of the tumor microenvironment using integrative networks and bioinformatic tools INSERM U872, Jerome Galon Team15: Integrative Cancer Immunology Cordeliers Research Center, Paris, France

Medical Informatics II

Medical Informatics II Medical Informatics II Zlatko Trajanoski Institute for Genomics and Bioinformatics Graz University of Technology http://genome.tugraz.at zlatko.trajanoski@tugraz.at Medical Informatics II Introduction

More information

Identification of rheumatoid arthritis and osteoarthritis patients by transcriptome-based rule set generation

Identification of rheumatoid arthritis and osteoarthritis patients by transcriptome-based rule set generation Identification of rheumatoid arthritis and osterthritis patients by transcriptome-based rule set generation Bering Limited Report generated on September 19, 2014 Contents 1 Dataset summary 2 1.1 Project

More information

Vad är bioinformatik och varför behöver vi det i vården? a bioinformatician's perspectives

Vad är bioinformatik och varför behöver vi det i vården? a bioinformatician's perspectives Vad är bioinformatik och varför behöver vi det i vården? a bioinformatician's perspectives Dirk.Repsilber@oru.se 2015-05-21 Functional Bioinformatics, Örebro University Vad är bioinformatik och varför

More information

Visualizing Networks: Cytoscape. Prat Thiru

Visualizing Networks: Cytoscape. Prat Thiru Visualizing Networks: Cytoscape Prat Thiru Outline Introduction to Networks Network Basics Visualization Inferences Cytoscape Demo 2 Why (Biological) Networks? 3 Networks: An Integrative Approach Zvelebil,

More information

An Introduction To Immunotherapy And The Promise Of Tissue Phenomics

An Introduction To Immunotherapy And The Promise Of Tissue Phenomics An Introduction To Immunotherapy And The Promise Of Tissue Phenomics INSIDE: n The Potential of Immunotherapy n Towards an Understanding of Immunotherapy n Current Approaches to Immunotherapy n The Immunotherapy

More information

Course on Functional Analysis. ::: Gene Set Enrichment Analysis - GSEA -

Course on Functional Analysis. ::: Gene Set Enrichment Analysis - GSEA - Course on Functional Analysis ::: Madrid, June 31st, 2007. Gonzalo Gómez, PhD. ggomez@cnio.es Bioinformatics Unit CNIO ::: Contents. 1. Introduction. 2. GSEA Software 3. Data Formats 4. Using GSEA 5. GSEA

More information

Exercise with Gene Ontology - Cytoscape - BiNGO

Exercise with Gene Ontology - Cytoscape - BiNGO Exercise with Gene Ontology - Cytoscape - BiNGO This practical has material extracted from http://www.cbs.dtu.dk/chipcourse/exercises/ex_go/goexercise11.php In this exercise we will analyze microarray

More information

Overview. Transcriptional cascades. Amazing aspects of lineage plasticity. Conventional (B2) B cell development

Overview. Transcriptional cascades. Amazing aspects of lineage plasticity. Conventional (B2) B cell development Overview B cell development Transcriptional cascades Amazing aspects of lineage plasticity Conventional (B2) B cell development What happens to an autoreactive B cell? B1 vs B2 cells Key anatomical sites

More information

Ensemble Learning of Colorectal Cancer Survival Rates

Ensemble Learning of Colorectal Cancer Survival Rates Ensemble Learning of Colorectal Cancer Survival Rates Chris Roadknight School of Computing Science University of Nottingham Malaysia Campus Malaysia Chris.roadknight@nottingham.edu.my Uwe Aickelin School

More information

Survey of clinical data mining applications on big data in health informatics

Survey of clinical data mining applications on big data in health informatics Survey of clinical data mining applications on big data in health informatics Matthew Herland, Taghi M. Khoshgoftaar, and Randall Wald 劉 俊 成 Survey of clinical data mining applications on big data in health

More information

AGILENT S BIOINFORMATICS ANALYSIS SOFTWARE

AGILENT S BIOINFORMATICS ANALYSIS SOFTWARE ACCELERATING PROGRESS IS IN OUR GENES AGILENT S BIOINFORMATICS ANALYSIS SOFTWARE GENESPRING GENE EXPRESSION (GX) MASS PROFILER PROFESSIONAL (MPP) PATHWAY ARCHITECT (PA) See Deeper. Reach Further. BIOINFORMATICS

More information

Methods for network visualization and gene enrichment analysis July 17, 2013. Jeremy Miller Scientist I jeremym@alleninstitute.org

Methods for network visualization and gene enrichment analysis July 17, 2013. Jeremy Miller Scientist I jeremym@alleninstitute.org Methods for network visualization and gene enrichment analysis July 17, 2013 Jeremy Miller Scientist I jeremym@alleninstitute.org Outline Visualizing networks using R Visualizing networks using outside

More information

Predictive Biomarkers for PD1 Pathway Inhibitor Immunotherapy

Predictive Biomarkers for PD1 Pathway Inhibitor Immunotherapy Predictive Biomarkers for PD1 Pathway Inhibitor Immunotherapy Michael B. Atkins, M.D. Deputy Director Georgetown-Lombardi Comprehensive Cancer Center Michael Atkins, MD Consulting Fees (e.g., advisory

More information

Bioinformatics Grid - Enabled Tools For Biologists.

Bioinformatics Grid - Enabled Tools For Biologists. Bioinformatics Grid - Enabled Tools For Biologists. What is Grid-Enabled Tools (GET)? As number of data from the genomics and proteomics experiment increases. Problems arise for the current sequence analysis

More information

Cancer Genomics: What Does It Mean for You?

Cancer Genomics: What Does It Mean for You? Cancer Genomics: What Does It Mean for You? The Connection Between Cancer and DNA One person dies from cancer each minute in the United States. That s 1,500 deaths each day. As the population ages, this

More information

Ph.D. in Molecular Medicine

Ph.D. in Molecular Medicine Ph.D. in Molecular Medicine and Translational Research College of Medicine 1. Introduction: The College of Medicine, while consolidating on its undergraduate innovative educational programs, decided to

More information

Dr Alexander Henzing

Dr Alexander Henzing Horizon 2020 Health, Demographic Change & Wellbeing EU funding, research and collaboration opportunities for 2016/17 Innovate UK funding opportunities in omics, bridging health and life sciences Dr Alexander

More information

PREDA S4-classes. Francesco Ferrari October 13, 2015

PREDA S4-classes. Francesco Ferrari October 13, 2015 PREDA S4-classes Francesco Ferrari October 13, 2015 Abstract This document provides a description of custom S4 classes used to manage data structures for PREDA: an R package for Position RElated Data Analysis.

More information

IKDT Laboratory. IKDT as Service Lab (CRO) for Molecular Diagnostics

IKDT Laboratory. IKDT as Service Lab (CRO) for Molecular Diagnostics Page 1 IKDT Laboratory IKDT as Service Lab (CRO) for Molecular Diagnostics IKDT lab offer is complete diagnostic service to all external customers. We could perform as well single procedures or complex

More information

Oncos Therapeutics: ONCOS THERAPEUTICS Personalized Cancer Immunotherapy. March 2015. Antti Vuolanto, COO and co-founder

Oncos Therapeutics: ONCOS THERAPEUTICS Personalized Cancer Immunotherapy. March 2015. Antti Vuolanto, COO and co-founder Oncos Therapeutics: Personalized Cancer Immunotherapy ONCOS THERAPEUTICS Personalized Cancer Immunotherapy March 2015 Antti Vuolanto, COO and co-founder 1 History of Oncos Therapeutics 2002 2007 2009 Research

More information

CD22 Antigen Is Broadly Expressed on Lung Cancer Cells and Is a Target for Antibody-Based Therapy

CD22 Antigen Is Broadly Expressed on Lung Cancer Cells and Is a Target for Antibody-Based Therapy CD22 Antigen Is Broadly Expressed on Lung Cancer Cells and Is a Target for Antibody-Based Therapy Joseph M. Tuscano, Jason Kato, David Pearson, Chengyi Xiong, Laura Newell, Yunpeng Ma, David R. Gandara,

More information

Pathway Analysis : An Introduction

Pathway Analysis : An Introduction Pathway Analysis : An Introduction Experiments Literature and other KB Data Knowledge Structure in Data through statistics Structure in Knowledge through GO and other Ontologies Gain insight into Data

More information

Robert Bristow MD PhD FRCPC

Robert Bristow MD PhD FRCPC Robert Bristow MD PhD FRCPC Clinician-Scientist and Professor, Radiation Oncology and Medical Biophysics, University of Toronto and Ontario Cancer Institute/ (UHN) Head, PMH-CFCRI Prostate Cancer Research

More information

Targeted Therapy What the Surgeon Needs to Know

Targeted Therapy What the Surgeon Needs to Know Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures

More information

InSyBio BioNets: Utmost efficiency in gene expression data and biological networks analysis

InSyBio BioNets: Utmost efficiency in gene expression data and biological networks analysis InSyBio BioNets: Utmost efficiency in gene expression data and biological networks analysis WHITE PAPER By InSyBio Ltd Konstantinos Theofilatos Bioinformatician, PhD InSyBio Technical Sales Manager August

More information

Multiple Myeloma and Colorectal Cancer

Multiple Myeloma and Colorectal Cancer Multiple Myeloma and Colorectal Cancer From Systems Immunology to Single Cells Leo Hansmann Mark M. Davis Lab Department of Microbiology&Immunology Stanford University Multiple Myeloma Monoclonal disease

More information

Lecture 11 Data storage and LIMS solutions. Stéphane LE CROM lecrom@biologie.ens.fr

Lecture 11 Data storage and LIMS solutions. Stéphane LE CROM lecrom@biologie.ens.fr Lecture 11 Data storage and LIMS solutions Stéphane LE CROM lecrom@biologie.ens.fr Various steps of a DNA microarray experiment Experimental steps Data analysis Experimental design set up Chips on catalog

More information

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins Adaptive Immunity Chapter 17: Adaptive (specific) Immunity Bio 139 Dr. Amy Rogers Host defenses that are specific to a particular infectious agent Can be innate or genetic for humans as a group: most microbes

More information

Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer

Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer J.-L. Zhang, Q. Yao, J.-H. Chen,Y. Wang, H. Wang, Q. Fan, R. Ling, J. Yi and L. Wang Xijing Hospital Vascular Endocrine

More information

Guide for Data Visualization and Analysis using ACSN

Guide for Data Visualization and Analysis using ACSN Guide for Data Visualization and Analysis using ACSN ACSN contains the NaviCell tool box, the intuitive and user- friendly environment for data visualization and analysis. The tool is accessible from the

More information

Pharmacogenetic Activities in SWOG Breast Cancer

Pharmacogenetic Activities in SWOG Breast Cancer Pharmacogenetic Activities in SWOG Breast Cancer Pharmacogenomics: Future Plans S8897 Adjuvant CMF vs. CAF/ no Treatment Ambrosone RO1: Other genes (TBCI approved, analyses ongoing) S0221 Adjuvant Dose

More information

ProteinQuest user guide

ProteinQuest user guide ProteinQuest user guide 1. Introduction... 3 1.1 With ProteinQuest you can... 3 1.2 ProteinQuest basic version 4 1.3 ProteinQuest extended version... 5 2. ProteinQuest dictionaries... 6 3. Directions for

More information

Pulling the Plug on Cancer Cell Communication. Stephen M. Ansell, MD, PhD Mayo Clinic

Pulling the Plug on Cancer Cell Communication. Stephen M. Ansell, MD, PhD Mayo Clinic Pulling the Plug on Cancer Cell Communication Stephen M. Ansell, MD, PhD Mayo Clinic Why do Waldenstrom s cells need to communicate? Waldenstrom s cells need activating signals to stay alive. WM cells

More information

Using the Grid for the interactive workflow management in biomedicine. Andrea Schenone BIOLAB DIST University of Genova

Using the Grid for the interactive workflow management in biomedicine. Andrea Schenone BIOLAB DIST University of Genova Using the Grid for the interactive workflow management in biomedicine Andrea Schenone BIOLAB DIST University of Genova overview background requirements solution case study results background A multilevel

More information

INSERM/ A. Bernheim. Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance

INSERM/ A. Bernheim. Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance A. Bernheim Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance OVER-MyR is funded by the European Commission within its FP7 specific

More information

Analysis of gene expression data. Ulf Leser and Philippe Thomas

Analysis of gene expression data. Ulf Leser and Philippe Thomas Analysis of gene expression data Ulf Leser and Philippe Thomas This Lecture Protein synthesis Microarray Idea Technologies Applications Problems Quality control Normalization Analysis next week! Ulf Leser:

More information

Bioinformatics for cancer immunology and immunotherapy

Bioinformatics for cancer immunology and immunotherapy Bioinformatics for cancer immunology and immunotherapy Zlatko Trajanoski Biocenter, Division for Bioinformatics Innsbruck Medical University Innrain 80, 6020 Innsbruck, Austria Email: zlatko.trajanoski@i-med.ac.at

More information

How to report Upper GI EMR/ESD specimens

How to report Upper GI EMR/ESD specimens Section of Pathology and Tumour Biology How to report Upper GI EMR/ESD specimens Dr.H.Grabsch Warning. Most of the criteria, methodologies, evidence presented in this talk are based on studies in early

More information

HAVE YOU BEEN NEWLY DIAGNOSED with DCIS?

HAVE YOU BEEN NEWLY DIAGNOSED with DCIS? HAVE YOU BEEN NEWLY DIAGNOSED with DCIS? Jen D. Mother and volunteer. Diagnosed with DCIS breast cancer in 2012. An educational guide prepared by Genomic Health This guide is designed to educate women

More information

Gene expression analysis. Ulf Leser and Karin Zimmermann

Gene expression analysis. Ulf Leser and Karin Zimmermann Gene expression analysis Ulf Leser and Karin Zimmermann Ulf Leser: Bioinformatics, Wintersemester 2010/2011 1 Last lecture What are microarrays? - Biomolecular devices measuring the transcriptome of a

More information

Lung Carcinomas New 2015 WHO Classification. Spasenija Savic Pathology

Lung Carcinomas New 2015 WHO Classification. Spasenija Savic Pathology Lung Carcinomas New 2015 WHO Classification Spasenija Savic Pathology ***EXPECTED SPRING 2015*** This authoritative, concise reference book provides an international standard for oncologists and pathologists

More information

Lymph Nodes and Cancer What is the lymph system?

Lymph Nodes and Cancer What is the lymph system? Lymph Nodes and Cancer What is the lymph system? Our bodies have a network of lymph vessels and lymph nodes. (Lymph is pronounced limf.) This network is a part of the body s immune system. It collects

More information

CCR Biology - Chapter 9 Practice Test - Summer 2012

CCR Biology - Chapter 9 Practice Test - Summer 2012 Name: Class: Date: CCR Biology - Chapter 9 Practice Test - Summer 2012 Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Genetic engineering is possible

More information

BIOINF 525 Winter 2016 Foundations of Bioinformatics and Systems Biology http://tinyurl.com/bioinf525-w16

BIOINF 525 Winter 2016 Foundations of Bioinformatics and Systems Biology http://tinyurl.com/bioinf525-w16 Course Director: Dr. Barry Grant (DCM&B, bjgrant@med.umich.edu) Description: This is a three module course covering (1) Foundations of Bioinformatics, (2) Statistics in Bioinformatics, and (3) Systems

More information

Analysis of Illumina Gene Expression Microarray Data

Analysis of Illumina Gene Expression Microarray Data Analysis of Illumina Gene Expression Microarray Data Asta Laiho, Msc. Tech. Bioinformatics research engineer The Finnish DNA Microarray Centre Turku Centre for Biotechnology, Finland The Finnish DNA Microarray

More information

The immune system. Bone marrow. Thymus. Spleen. Bone marrow. NK cell. B-cell. T-cell. Basophil Neutrophil. Eosinophil. Myeloid progenitor

The immune system. Bone marrow. Thymus. Spleen. Bone marrow. NK cell. B-cell. T-cell. Basophil Neutrophil. Eosinophil. Myeloid progenitor The immune system Basophil Neutrophil Bone marrow Eosinophil Myeloid progenitor Dendritic cell Pluripotent Stem cell Lymphoid progenitor Platelets Bone marrow Thymus NK cell T-cell B-cell Spleen Cancer

More information

Understanding West Nile Virus Infection

Understanding West Nile Virus Infection Understanding West Nile Virus Infection The QIAGEN Bioinformatics Solution: Biomedical Genomics Workbench (BXWB) + Ingenuity Pathway Analysis (IPA) Functional Genomics & Predictive Medicine, May 21-22,

More information

Update in Hematology Oncology Targeted Therapies. Mark Holguin

Update in Hematology Oncology Targeted Therapies. Mark Holguin Update in Hematology Oncology Targeted Therapies Mark Holguin 25 years ago Why I chose oncology People How to help people with possibly the most difficult thing they may have to deal with Science Turning

More information

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Second Opinion in Breast Pathology Usually requested when a patient is referred

More information

Does my patient need more therapy after prostate cancer surgery?

Does my patient need more therapy after prostate cancer surgery? Does my patient need more therapy after prostate cancer surgery? Contact the GenomeDx Patient Care Team at: 1.888.792.1601 (toll-free) or e-mail: client.service@genomedx.com Prostate Cancer Classifier

More information

Big Data Problem? or Big Problem with Data? William Hayes, PhD SVP PlaCorm Dev, Selventa

Big Data Problem? or Big Problem with Data? William Hayes, PhD SVP PlaCorm Dev, Selventa Big Data Problem? or Big Problem with Data? William Hayes, PhD SVP PlaCorm Dev, Selventa 2013, Selventa. All Rights Reserved. Confiden;al 1 Who am I? ex- Aerospace Engineer Defected to Bioinforma;cs (PhD

More information

Comparison of Non-linear Dimensionality Reduction Techniques for Classification with Gene Expression Microarray Data

Comparison of Non-linear Dimensionality Reduction Techniques for Classification with Gene Expression Microarray Data CMPE 59H Comparison of Non-linear Dimensionality Reduction Techniques for Classification with Gene Expression Microarray Data Term Project Report Fatma Güney, Kübra Kalkan 1/15/2013 Keywords: Non-linear

More information

Special report. Chronic Lymphocytic Leukemia (CLL) Genomic Biology 3020 April 20, 2006

Special report. Chronic Lymphocytic Leukemia (CLL) Genomic Biology 3020 April 20, 2006 Special report Chronic Lymphocytic Leukemia (CLL) Genomic Biology 3020 April 20, 2006 Gene And Protein The gene that causes the mutation is CCND1 and the protein NP_444284 The mutation deals with the cell

More information

Department of BioScience Technology Chung Yuan Christian University 2015/08/13

Department of BioScience Technology Chung Yuan Christian University 2015/08/13 Department of BioScience Technology Chung Yuan Christian University 2015/08/13 Cancer Cells Cancer, the 1st leading cause of death, is an example of a disease that arises from abnormalities in cell function

More information

What is Cancer? Cancer is a genetic disease: Cancer typically involves a change in gene expression/function:

What is Cancer? Cancer is a genetic disease: Cancer typically involves a change in gene expression/function: Cancer is a genetic disease: Inherited cancer Sporadic cancer What is Cancer? Cancer typically involves a change in gene expression/function: Qualitative change Quantitative change Any cancer causing genetic

More information

Protein Protein Interaction Networks

Protein Protein Interaction Networks Functional Pattern Mining from Genome Scale Protein Protein Interaction Networks Young-Rae Cho, Ph.D. Assistant Professor Department of Computer Science Baylor University it My Definition of Bioinformatics

More information

FACULTY OF MEDICAL SCIENCE

FACULTY OF MEDICAL SCIENCE Doctor of Philosophy in Biochemistry FACULTY OF MEDICAL SCIENCE Naresuan University 73 Doctor of Philosophy in Biochemistry The Biochemistry Department at Naresuan University is a leader in lower northern

More information

H. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland School of Medicine Baltimore, Md

H. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland School of Medicine Baltimore, Md Major Advances in Cancer Prevention, Diagnosis and Treatment~ Why Mesothelioma Leads the Way H. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland

More information

SINPE trial, Ann Surg 2009. Overall morbidity. Minor Major. Infectious Non infectious. Post-hoc analysis WL < %5 (n=379) WL between 5-10% (n=49)

SINPE trial, Ann Surg 2009. Overall morbidity. Minor Major. Infectious Non infectious. Post-hoc analysis WL < %5 (n=379) WL between 5-10% (n=49) Chinese International Symposium on Nutritional Oncology Changchun, June 20-21 2014 IMMUNONUTRITION IN CANCER PATIENTS IMMUNONUTRITION IN SURGERY OBJECTIVE To get the patient undergoing major surgery for

More information

Microarray Data Analysis. A step by step analysis using BRB-Array Tools

Microarray Data Analysis. A step by step analysis using BRB-Array Tools Microarray Data Analysis A step by step analysis using BRB-Array Tools 1 EXAMINATION OF DIFFERENTIAL GENE EXPRESSION (1) Objective: to find genes whose expression is changed before and after chemotherapy.

More information

treatments) worked by killing cancerous cells using chemo or radiotherapy. While these techniques can

treatments) worked by killing cancerous cells using chemo or radiotherapy. While these techniques can Shristi Pandey Genomics and Medicine Winter 2011 Prof. Doug Brutlag Chronic Myeloid Leukemia: A look into how genomics is changing the way we treat Cancer. Until the late 1990s, nearly all treatment methods

More information

Gene Expression Analysis

Gene Expression Analysis Gene Expression Analysis Jie Peng Department of Statistics University of California, Davis May 2012 RNA expression technologies High-throughput technologies to measure the expression levels of thousands

More information

MultiExperiment Viewer Quickstart Guide

MultiExperiment Viewer Quickstart Guide MultiExperiment Viewer Quickstart Guide Table of Contents: I. Preface - 2 II. Installing MeV - 2 III. Opening a Data Set - 2 IV. Filtering - 6 V. Clustering a. HCL - 8 b. K-means - 11 VI. Modules a. T-test

More information

Data Integration and Knowledge Management within Oncotyrol A. Dander, R. Gallasch, S. Pabinger, H. Fiegl, Z. Trajanoski

Data Integration and Knowledge Management within Oncotyrol A. Dander, R. Gallasch, S. Pabinger, H. Fiegl, Z. Trajanoski Data Integration and Knowledge Management within Oncotyrol A. Dander, R. Gallasch, S. Pabinger, H. Fiegl, Z. Trajanoski Oncotyrol, Center for Personalized Cancer Medicine, Innsbruck, Austria Biocenter,

More information

Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical

Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical Summary. 111 Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical recurrence (BCR) is the first sign of recurrent

More information

Software reviews. Expression Pro ler: A suite of web-based tools for the analysis of microarray gene expression data

Software reviews. Expression Pro ler: A suite of web-based tools for the analysis of microarray gene expression data Expression Pro ler: A suite of web-based tools for the analysis of microarray gene expression data DNA microarray analysis 1±3 has become one of the most widely used tools for the analysis of gene expression

More information

A disease and antibody biology approach to antibody drug discovery

A disease and antibody biology approach to antibody drug discovery A disease and antibody biology approach to antibody drug discovery Björn Frendéus, PhD VP, Preclinical research Presenter: Björn Frendéus Date: 2011-11-08 1 Antibodies have revolutionized Cancer Treatment!

More information

Predictive Biomarkers for Tumor Immunotherapy: Are we ready for clinical implementation? Howard L. Kaufman Rush University

Predictive Biomarkers for Tumor Immunotherapy: Are we ready for clinical implementation? Howard L. Kaufman Rush University Predictive Biomarkers for Tumor Immunotherapy: Are we ready for clinical implementation? Howard L. Kaufman Rush University Changing Paradigms in Cancer Treatment Potential Uses of Biomarkers Adverse event

More information

Comparative genomic hybridization Because arrays are more than just a tool for expression analysis

Comparative genomic hybridization Because arrays are more than just a tool for expression analysis Microarray Data Analysis Workshop MedVetNet Workshop, DTU 2008 Comparative genomic hybridization Because arrays are more than just a tool for expression analysis Carsten Friis ( with several slides from

More information

Integrating Chemotherapy and Liver Surgery for the Management of Colorectal Metastases

Integrating Chemotherapy and Liver Surgery for the Management of Colorectal Metastases I Congresso de Oncologia D Or July 5-6, 2013 Integrating Chemotherapy and Liver Surgery for the Management of Colorectal Metastases Michael A. Choti, MD, MBA, FACS Department of Surgery Johns Hopkins University

More information

Software and Methods for the Analysis of Affymetrix GeneChip Data. Rafael A Irizarry Department of Biostatistics Johns Hopkins University

Software and Methods for the Analysis of Affymetrix GeneChip Data. Rafael A Irizarry Department of Biostatistics Johns Hopkins University Software and Methods for the Analysis of Affymetrix GeneChip Data Rafael A Irizarry Department of Biostatistics Johns Hopkins University Outline Overview Bioconductor Project Examples 1: Gene Annotation

More information

SUMMARY. Randolph Fillmore, Florida Science Communications

SUMMARY. Randolph Fillmore, Florida Science Communications SUMMARY Randolph Fillmore, Florida Science Communications The H. Lee Moffitt Cancer Center held its first Advanced Prostate Cancer Collaboration roundtable discussion November 24, 2008. The roundtable

More information

How do plasma cells survive

How do plasma cells survive How do plasma cells survive Claudia Berek Deutsches Rheuma Forschungs Zentrum, Berlin Institut der Leibniz Gemeinschaft Immune response Naive B cell Peripheral lymphoid organs Memory B cell Germinal T

More information

LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials

LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials OUR FOCUS ABOUT emerging treatments Presentation for: Judith E. Karp, MD Advancements for Acute Myelogenous Leukemia Supported by an unrestricted educational

More information

Vitamin D deficiency exacerbates ischemic cell loss and sensory motor dysfunction in an experimental stroke model

Vitamin D deficiency exacerbates ischemic cell loss and sensory motor dysfunction in an experimental stroke model Vitamin D deficiency exacerbates ischemic cell loss and sensory motor dysfunction in an experimental stroke model Robyn Balden & Farida Sohrabji Texas A&M Health Science Center- College of Medicine ISC

More information

The DMD/PhD Program at UMDNJ-New Jersey Dental School And The Graduate School of Biomedical Sciences

The DMD/PhD Program at UMDNJ-New Jersey Dental School And The Graduate School of Biomedical Sciences The DMD/PhD Program at UMDNJ-New Jersey Dental School And The Graduate School of Biomedical Sciences I. Introduction Dental research is rapidly changing the face of clinical dentistry. Dental health and

More information

SYMPOSIUM. June 15, 2013. Photonics Center Colloquium Room (906) 8 Saint Mary's St., Boston, MA 02215 Boston University

SYMPOSIUM. June 15, 2013. Photonics Center Colloquium Room (906) 8 Saint Mary's St., Boston, MA 02215 Boston University SYMPOSIUM June 15, 2013 Photonics Center Colloquium Room (906) 8 Saint Mary's St., Boston, MA 02215 Bette Korber Los Alamos National Labs HIV evolution and the neutralizing antibody response We have recently

More information

GENETIC PROFILES AND TARGETED TREATMENT OF CANCER - PERSONALIZED MEDICINE

GENETIC PROFILES AND TARGETED TREATMENT OF CANCER - PERSONALIZED MEDICINE GENETIC PROFILES AND TARGETED TREATMENT OF CANCER - PERSONALIZED MEDICINE Branko Zakotnik MD, PhD Department of Medical Oncology Institute of Oncology Ljubljana 1 I have no conflict of interest to declare

More information

Supplementary Information

Supplementary Information Supplementary Information S1: Degree Distribution of TFs in the E.coli TRN and CRN based on Operons 1000 TRN Number of TFs 100 10 y = 619.55x -1.4163 R 2 = 0.8346 1 1 10 100 1000 Degree of TFs CRN 100

More information

Enhancing Anti-Tumor Activity of Checkpoint Inhibition

Enhancing Anti-Tumor Activity of Checkpoint Inhibition Enhancing Anti-Tumor Activity of Checkpoint Inhibition Jeffrey Schlom, Ph.D. Laboratory of Tumor Immunology and Biology (LTIB) Center for Cancer Research National Cancer Institute, NIH Laboratory of Tumor

More information

Report series: General cancer information

Report series: General cancer information Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for

More information

LESSON 3: ANTIBODIES/BCR/B-CELL RESPONSES

LESSON 3: ANTIBODIES/BCR/B-CELL RESPONSES Introduction to immunology. LESSON 3: ANTIBODIES/BCR/B-CELL RESPONSES Today we will get to know: The antibodies How antibodies are produced, their classes and their maturation processes Antigen recognition

More information

BioPATH: A Study of Biomarker Profiles in Asia Pacific HER2 Breast Cancer Patients Treated with Lapatinib and Other Anti-HER2 Therapy

BioPATH: A Study of Biomarker Profiles in Asia Pacific HER2 Breast Cancer Patients Treated with Lapatinib and Other Anti-HER2 Therapy BioPATH: A Study of Biomarker Profiles in Asia Pacific HER2 Breast Cancer Patients Treated with Lapatinib and Other Anti-HER2 Therapy Soonmyung Paik 1 ; Gyungyub Gong 2 ; Yap Yoon Sim 3 ; Tae- You Kim

More information

Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle

Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle TITLE PROJET NOM HOPITAL Assessment of tumor angiogenesis using PET/CT with 18 F-Galacto- RGD. (PNC_29_001) Division of

More information

Big Data in Drug Discovery

Big Data in Drug Discovery Big Data in Drug Discovery David J. Wild Assistant Professor & Director, Cheminformatics Program Indiana University School of Informatics and Computing djwild@indiana.edu - http://djwild.info Epochs in

More information

Formalin fixation at low temperature better preserves nucleic acid integrity. Gianni Bussolati. University of Turin

Formalin fixation at low temperature better preserves nucleic acid integrity. Gianni Bussolati. University of Turin Formalin fixation at low temperature better preserves nucleic acid integrity Gianni Bussolati University of Turin Disclosure of interests: G.B. was originally responsible for the invention of the Cold

More information

How To Learn More About Melanoma

How To Learn More About Melanoma PROGRAMMA SCIENTIFICO MELANOMA BRIDGE 2012, DECEMBER 2 ND -4 TH 2012 Presidents: Paolo A. Ascierto, Francesco M. Marincola and Nicola Mozzillo Scientific Board Paolo A. Ascierto Gennaro Ciliberto Bernard

More information

Tutorial for proteome data analysis using the Perseus software platform

Tutorial for proteome data analysis using the Perseus software platform Tutorial for proteome data analysis using the Perseus software platform Laboratory of Mass Spectrometry, LNBio, CNPEM Tutorial version 1.0, January 2014. Note: This tutorial was written based on the information

More information

In developmental genomic regulatory interactions among genes, encoding transcription factors

In developmental genomic regulatory interactions among genes, encoding transcription factors JOURNAL OF COMPUTATIONAL BIOLOGY Volume 20, Number 6, 2013 # Mary Ann Liebert, Inc. Pp. 419 423 DOI: 10.1089/cmb.2012.0297 Research Articles A New Software Package for Predictive Gene Regulatory Network

More information

Chemotherapy or Not? Anthracycline or Not? Taxane or Not? Does Density Matter? Chemotherapy in Luminal Breast Cancer: Choice of Regimen.

Chemotherapy or Not? Anthracycline or Not? Taxane or Not? Does Density Matter? Chemotherapy in Luminal Breast Cancer: Choice of Regimen. Chemotherapy in Luminal Breast Cancer: Choice of Regimen Andrew D. Seidman, MD Attending Physician Breast Cancer Medicine Service Memorial Sloan Kettering Cancer Center Professor of Medicine Weill Cornell

More information

A truly robust Expression analyzer

A truly robust Expression analyzer Genowiz A truly robust Expression analyzer Abstract Gene expression profiles of 10,000 tumor samples, disease classification, novel gene finding, linkage analysis, clinical profiling of diseases, finding

More information

Next Generation Sequencing: Adjusting to Big Data. Daniel Nicorici, Dr.Tech. Statistikot Suomen Lääketeollisuudessa 29.10.2013

Next Generation Sequencing: Adjusting to Big Data. Daniel Nicorici, Dr.Tech. Statistikot Suomen Lääketeollisuudessa 29.10.2013 Next Generation Sequencing: Adjusting to Big Data Daniel Nicorici, Dr.Tech. Statistikot Suomen Lääketeollisuudessa 29.10.2013 Outline Human Genome Project Next-Generation Sequencing Personalized Medicine

More information

Adjuvant Therapy for Breast Cancer: Questions and Answers

Adjuvant Therapy for Breast Cancer: Questions and Answers CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Adjuvant Therapy for Breast

More information

LCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH

LCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH LCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH FUNDING OPPORTUNITY DESCRIPTION 2016 REQUEST FOR APPLICATION (RFA) Lung Cancer Foundation of America (LCFA) and the International

More information

Introduction To Real Time Quantitative PCR (qpcr)

Introduction To Real Time Quantitative PCR (qpcr) Introduction To Real Time Quantitative PCR (qpcr) SABiosciences, A QIAGEN Company www.sabiosciences.com The Seminar Topics The advantages of qpcr versus conventional PCR Work flow & applications Factors

More information

NeXO Web: the NeXO ontology database and visualization platform

NeXO Web: the NeXO ontology database and visualization platform Nucleic Acids Research Advance Access published November 23, 2013 Nucleic Acids Research, 2013, 1 6 doi:10.1093/nar/gkt1192 NeXO Web: the NeXO ontology database and visualization platform Janusz Dutkowski*,

More information

Appendix One. HER2-positive early breast cancer, its treatment and prognosis

Appendix One. HER2-positive early breast cancer, its treatment and prognosis Appendix One. HER2-positive early breast cancer, its treatment and prognosis Breast cancer and HER2/neu over-expression Health need is one of PHARMAC s nine decision criteria (http://www.pharmac.govt.nz/pdf/231205.pdf

More information

Identification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1

Identification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1 9/8/2015 Identification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1 Stefan Eichmüller, PhD GMP & T Cell Therapy Unit, German Cancer Research Center, Heidelberg, Germany

More information

Molecular markers and clinical trial design parallels between oncology and rare diseases?

Molecular markers and clinical trial design parallels between oncology and rare diseases? Molecular markers and clinical trial design parallels between oncology and rare diseases?, Harriet Sommer Institute for Medical Biometry and Statistics, University of Freiburg Medical Center 6. Forum Patientennahe

More information

COMMISSIONING. for ULTRA-RADICAL SURGERY ADVANCED OVARIAN CANCER

COMMISSIONING. for ULTRA-RADICAL SURGERY ADVANCED OVARIAN CANCER COMMISSIONING for ULTRA-RADICAL SURGERY in ADVANCED OVARIAN CANCER WHY THIS MUST HAPPEN PERSPECTIVE COMMISSIONING FOR WHO, FOR WHAT? Biological Basis Surgical Basis International and national standards

More information